<?xml version="1.0" encoding="UTF-8"?>
<p>From several studies, it has been found that approximately there are 140 genes that are responsible for selective growth advantage. These genes are termed as “driver” genes. As mentioned before in the 
 <italic>Background</italic>, mutations occur in a typical tumor due to two to eight such “driver” genes, while there are only twelve signaling pathways which allow selective growth advantage. These twelve signaling pathways (“target pathways”) are: 
 <inline-formula id="IEq1">
  <alternatives>
   <tex-math id="M1">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \mathrm{T}\mathrm{G}\mathrm{F} - \upbeta $$\end{document}</tex-math>
   <math id="M2">
    <mi mathvariant="normal">T</mi>
    <mi mathvariant="normal">G</mi>
    <mi mathvariant="normal">F</mi>
    <mspace width="0.12em"/>
    <mo>-</mo>
    <mspace width="0.12em"/>
    <mi mathvariant="normal">β</mi>
   </math>
   <inline-graphic xlink:href="13062_2016_168_Article_IEq1.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </alternatives>
 </inline-formula>, MAPK, STAT, PI3K, RAS, Cell Cycle/Apoptosis, NOTCH, HH, APC, Chromatin modification, Transcriptional regulation and DNA damage control. Among these, 
 <inline-formula id="IEq2">
  <alternatives>
   <tex-math id="M3">\documentclass[12pt]{minimal} \usepackage{amsmath} \usepackage{wasysym} \usepackage{amsfonts} \usepackage{amssymb} \usepackage{amsbsy} \usepackage{mathrsfs} \usepackage{upgreek} \setlength{\oddsidemargin}{-69pt} \begin{document}$$ \mathrm{T}\mathrm{G}\mathrm{F}-\upbeta $$\end{document}</tex-math>
   <math id="M4">
    <mi mathvariant="normal">T</mi>
    <mi mathvariant="normal">G</mi>
    <mi mathvariant="normal">F</mi>
    <mo>-</mo>
    <mi mathvariant="normal">β</mi>
   </math>
   <inline-graphic xlink:href="13062_2016_168_Article_IEq2.gif" xmlns:xlink="http://www.w3.org/1999/xlink"/>
  </alternatives>
 </inline-formula>, MAPK, STAT, PI3K, RAS and Cell Cycle/Apoptosis regulate “cell survival”; NOTCH, HH, APC, Chromatin modification and Transcriptional regulation regulate “cell fate”; while the DNA damage control signaling pathway regulates “genome maintenance”. We have separately analyzed the protein profiles of the three cancer types using “GO” clustering tool [
 <xref ref-type="bibr" rid="CR3">3</xref>, 
 <xref ref-type="bibr" rid="CR4">4</xref>] and grouped the proteins according to their biological pathways. As selective growth advantage can occur only through the “target pathways”, we have considered only the proteins included in the “target pathways” for our analysis.
</p>
